Radiation myelopathy following stereotactic body radiation therapy for spine metastases

[1]  Surabhi Ranjan,et al.  Successful treatment of quadriparesis from radiation myelopathy with bevacizumab in a patient with metastatic breast cancer , 2022, BMJ Case Reports.

[2]  I. Poon,et al.  An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  S. Lo,et al.  Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intra-Canal Spinal Nerve Roots for Spine Stereotactic Body Radiotherapy (SBRT): Contour Variability and Recommendations for Safe Practice. , 2021, International journal of radiation oncology, biology, physics.

[4]  M. Fehlings,et al.  Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. , 2021, The Lancet. Oncology.

[5]  P. Thall,et al.  Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously irradiated metastatic epidural spinal cord compression , 2021, North American Spine Society journal.

[6]  N. Lipsman,et al.  Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference , 2021, Journal of Neuro-Oncology.

[7]  Y. Nakajima,et al.  Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history. , 2020, Japanese journal of clinical oncology.

[8]  A. Sahgal,et al.  Evaluation of multi-institutional end-to-end testing for post-operative spine stereotactic body radiation therapy , 2020, Physics and imaging in radiation oncology.

[9]  P. Fennema,et al.  Carbon fiber-reinforced pedicle screws reduce artifacts in magnetic resonance imaging of patients with lumbar spondylodesis , 2020, Scientific Reports.

[10]  D. Garbossa,et al.  Separation surgery for metastatic epidural spinal cord compression: A qualitative review , 2020, Journal of bone oncology.

[11]  M. Chua,et al.  A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy , 2020, Clinical Cancer Research.

[12]  J. Fenderson,et al.  Diving Into Radiation Necrosis: Hyperbaric Oxygen Therapy in Cerebral Radiation Necrosis. , 2020, JCO oncology practice.

[13]  R. Saigal,et al.  The Dancing Cord: Inherent Spinal Cord Motion and Its Effect on Cord Dose in Spine Stereotactic Body Radiation Therapy , 2020, Neurosurgery.

[14]  Timothy K. Nguyen,et al.  Mature Imaging-Based Outcomes Supporting Local Control for Complex Re-Irradiation Salvage Spine Stereotactic Body Radiotherapy. , 2020, Neurosurgery.

[15]  Y. Yamada,et al.  Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review. , 2020, JAMA oncology.

[16]  E. Yorke,et al.  Spinal cord dose tolerance to stereotactic body radiotherapy. , 2019, International journal of radiation oncology, biology, physics.

[17]  Á. Lassaletta,et al.  Treatment of radiation-induced myelopathy with bevacizumab , 2019, Clinical and Translational Oncology.

[18]  V. Yang,et al.  Surgical Resection With Radiation Treatment Planning of Spinal Tumors. , 2019, Neurosurgery.

[19]  Michael Lock,et al.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial , 2019, The Lancet.

[20]  Jefferson R. Wilson,et al.  Postoperative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade. , 2019, Neurosurgery.

[21]  A. Yee,et al.  Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT). , 2018, International journal of radiation oncology, biology, physics.

[22]  Yi Li,et al.  Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial. , 2018, International journal of radiation oncology, biology, physics.

[23]  N. Mayr,et al.  The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases , 2018, Expert review of anticancer therapy.

[24]  P. Brown,et al.  Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression. , 2017, International journal of radiation oncology, biology, physics.

[25]  P. Brown,et al.  Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. , 2015, The Cochrane database of systematic reviews.

[26]  Y. Yamada,et al.  A Detailed Dosimetric Analysis of Spinal Cord Tolerance in High-Dose Spine Radiosurgery. , 2017, International journal of radiation oncology, biology, physics.

[27]  J. Régis,et al.  Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. , 2017, Journal of neurosurgery. Spine.

[28]  T. Eade,et al.  Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

[29]  P. Brown,et al.  Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. , 2017, Journal of neurosurgery. Spine.

[30]  Y. Yamada,et al.  Stereotactic Body Radiotherapy for Spinal Metastases: What are the Risks and How Do We Minimize Them? , 2016, Spine.

[31]  M. Ahluwalia,et al.  Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma. , 2016, Journal of neurosurgery. Spine.

[32]  J. Flickinger,et al.  Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. , 2016, Journal of neurosurgery. Spine.

[33]  M. Fehlings,et al.  Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation. , 2016, Journal of neurosurgery. Spine.

[34]  F. Ducray,et al.  Bevacizumab in late-onset radiation-induced myelopathy , 2016, Neurology.

[35]  J. Habrand,et al.  Vemurafenib and concomitant stereotactic radiation for the treatment of melanoma with spinal metastases: A case report. , 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[36]  Susan M. Chang,et al.  Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. , 2015, The Lancet. Oncology.

[37]  M. Fehlings,et al.  Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases. , 2015, International Journal of Radiation Oncology, Biology, Physics.

[38]  Lijun Ma,et al.  Magnetic resonance imaging assessment of spinal cord and cauda equina motion in supine patients with spinal metastases planned for spine stereotactic body radiation therapy. , 2015, International journal of radiation oncology, biology, physics.

[39]  A. Sahgal,et al.  Pathobiology of radiation myelopathy and strategies to mitigate injury , 2015, Spinal Cord.

[40]  B. Schmutz,et al.  Metal artifacts from titanium and steel screws in CT, 1.5T and 3T MR images of the tibial Pilon: a quantitative assessment in 3D. , 2014, Quantitative imaging in medicine and surgery.

[41]  M. Fehlings,et al.  Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy. , 2013, Neuro-oncology.

[42]  Y. Yamada,et al.  Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. , 2013, Journal of neurosurgery. Spine.

[43]  P. Gerszten,et al.  Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. , 2013, International journal of radiation oncology, biology, physics.

[44]  J. Flickinger,et al.  Radiosurgery for benign tumors of the spine using the Synergy S with cone-beam computed tomography image guidance. , 2012, Journal of neurosurgery.

[45]  David A Jaffray,et al.  Impact of immobilization on intrafraction motion for spine stereotactic body radiotherapy using cone beam computed tomography. , 2012, International journal of radiation oncology, biology, physics.

[46]  Scott Soltys,et al.  International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. , 2012, International journal of radiation oncology, biology, physics.

[47]  Dong Han Lee,et al.  Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group , 2012, Acta oncologica.

[48]  Lijun Ma,et al.  Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic couch: intrafraction motion analysis accounting for all six degrees of freedom. , 2012, International journal of radiation oncology, biology, physics.

[49]  J. Fowler,et al.  Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[50]  M. Chamberlain,et al.  Radiation-induced myelopathy: treatment with bevacizumab. , 2011, Archives of neurology.

[51]  N. Haseke,et al.  Simultaneous anti‐angiogenic therapy and single‐fraction radiosurgery in clinically relevant metastases from renal cell carcinoma , 2011, BJU international.

[52]  Walter J. Curran,et al.  Stereotactic Body Radiosurgery for Spinal Metastatic Disease: An Evidence-Based Review , 2011, International journal of surgical oncology.

[53]  M. Gilbert,et al.  Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. , 2011, International journal of radiation oncology, biology, physics.

[54]  Steven D Chang,et al.  Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas. , 2009, International journal of radiation oncology, biology, physics.

[55]  Lijun Ma,et al.  Nonrandom intrafraction target motions and general strategy for correction of spine stereotactic body radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[56]  Lijun Ma,et al.  Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. , 2009, International journal of radiation oncology, biology, physics.

[57]  P. Bondiau,et al.  CYBERKNIFE STEREOTACTIC RADIOTHERAPY FOR SPINAL TUMORS: VALUE OF COMPUTED TOMOGRAPHIC MYELOGRAPHY IN SPINAL CORD DELINEATION , 2009, Neurosurgery.

[58]  D. Kondziolka,et al.  Adverse Radiation Effects after Radiosurgery May Benefit from Oral Vitamin E and Pentoxifylline Therapy: A Pilot Study , 2008, Stereotactic and Functional Neurosurgery.

[59]  Lawrence B Marks,et al.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.

[60]  David J Brenner,et al.  The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. , 2008, Seminars in radiation oncology.

[61]  T. Schultheiss.  The radiation dose-response of the human spinal cord. , 2008, International journal of radiation oncology, biology, physics.

[62]  Lijun Ma,et al.  Image-Guided Robotic Stereotactic Body Radiotherapy for Benign Spinal Tumors: The University of California San Francisco Preliminary Experience , 2007, Technology in cancer research & treatment.

[63]  K. Sheng,et al.  Evaluation of thoracic spinal cord motion using dynamic MRI. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  A. Grosu,et al.  Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. , 2006, International journal of radiation oncology, biology, physics.

[65]  A. Grosu,et al.  Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. , 2005, International journal of radiation oncology, biology, physics.

[66]  M. Pintilie,et al.  Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury , 2004, Clinical Cancer Research.

[67]  Radhe Mohan,et al.  Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. , 2003, International journal of radiation oncology, biology, physics.

[68]  J. Jinkins,et al.  MRI of radiation myelitis: a report of a case treated with hyperbaric oxygen , 2000, European Radiology.

[69]  A. Friedman,et al.  Treatment of radiation‐induced nervous system injury with heparin and warfarin , 1994, Neurology.

[70]  J. Van Dyk,et al.  Radiation myelopathy following single courses of radiotherapy and retreatment. , 1994, International journal of radiation oncology, biology, physics.

[71]  K. Luk,et al.  Hyperbaric oxygen after radiation and its effect on the production of radiation myelitis. , 1978, International journal of radiation oncology, biology, physics.

[72]  T. Delozier,et al.  Radiation myelopathy of the cervical spinal cord: time, dose and volume factors. , 1978, International journal of radiation oncology, biology, physics.